ERBB2 and breast neoplasm: Considering the heterogeneous aspects of breast tumors, the therapeutic approach relies chiefly on the administration of endocrine therapy for hormone-sensitive cancers, anti-HER2 targeted therapy for HER2-enriched tumors, and chemotherapy, which constitutes the gold standard treatment for TNBC.